Skip to content

In the BioHarmony Drug Report Database

Uracil mustard

Uracil Mustard (uracil mustard) is a small molecule pharmaceutical. Uracil mustard was first approved as Uracil Mustard on 1982-01-01. It is used to treat b-cell chronic lymphocytic leukemia, bcr-abl positive chronic myelogenous leukemia, mycosis fungoides, ovarian neoplasms, and polycythemia vera amongst others in the USA.
Trade Name Uracil Mustard
Common Name Uracil mustard
Indication b-cell chronic lymphocytic leukemia, bcr-abl positive chronic myelogenous leukemia, mycosis fungoides, ovarian neoplasms, polycythemia vera, thrombocytosis
Drug Class Uracil type antineoplastics
Uracil mustard
Get full access now